Topic
rheumatology
1 stories related to this topic, newest first.
manilatimes.netpolitics4 days ago
Cullinan Therapeutics Presents Phase 1 Data on CLN-978 at EULAR 2026 Congress
Cullinan Therapeutics reported initial clinical results from two Phase 1 trials of CLN-978, a CD19xCD3 T cell engager, in patients with systemic lupus erythematosus and rheumatoid arthritis. The data were presented June 6 at the European Alliance of Associations for Rheumatology…